J. Marc Simard

University Of Maryland Baltimore

$20,591,919

Attributed

$21,930,762

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2005–25

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$21,930,762 · 10

VA$0 · 4

By mechanism

R01$21,930,762 · 10

I01$0 · 4

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

Margaret M McCarthy$23,935,328
Cedric X Yu$3,773,246
Muhammad G Saleh$1,093,596
Thomas A Blanpied$14,478,298
L. Elliot Hong$24,654,132

Others in their field

Top investigators on “Glyburide”

Mary F Hebert · University Of Washington$6,521,942
Timothy J Koh · University Of Illinois At Chicago$5,505,343
Sean P Hennessy · University Of Pennsylvania$5,147,870
Show-Ling Shyng · Oregon Health & Science University$4,557,593
Ruchira Menka Jha · University Of Pittsburgh At Pittsburgh$3,858,182
Gary D Hankins · University Of Texas Medical Br Galveston$3,542,881

Research focus

GlyburideMolecularPlayBrainLinkCellsTissuesIn VivoNeuronsInflammationAffectAstrocytesFunctional DisorderEdemaNeuroinflammationSignal TransductionPublic Health RelevanceIn VitroCell DeathPatch ClampGenesRattusResearch StudyMediating

Grant awards (84)

Aquaporin-4 regulation by NCX1 in post-ischemic brain swelling$386,250

R01 · FY2025 · NS · contact PI

Aquaporin-4 regulation by NCX1 in post-ischemic brain swelling$374,663

R01 · FY2024 · NS · contact PI

Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0

I01 · FY2024 · VA

Aquaporin-4 regulation by NCX1 in post-ischemic brain swelling$386,250

R01 · FY2023 · NS · contact PI

Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0

I01 · FY2023 · VA

Therapeutic potential and the critical site of action of non-addicting glibenclamide in neuropathic pain$0

I01 · FY2023 · VA · contact PI

Aquaporin-4 regulation by NCX1 in post-ischemic brain swelling$386,250

R01 · FY2022 · NS · contact PI

Fn14, non-canonical NF-kappaB and downstream signaling in neuropathic pain$373,122

R01 · FY2022 · NS · contact PI

Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0

I01 · FY2022 · VA

Therapeutic potential and the critical site of action of non-addicting glibenclamide in neuropathic pain$0

I01 · FY2022 · VA · contact PI

Astrocyte regulation of the blood-brain barrier in intracerebral hemorrhage$386,250

R01 · FY2021 · HL · contact PI

Fn14, non-canonical NF-kappaB and downstream signaling in neuropathic pain$373,122

R01 · FY2021 · NS · contact PI

Non-canonical NF-kappaB signaling and Sur1-Trpm4 in traumatic brain injury$337,969

R01 · FY2021 · NS · contact PI

Therapeutic potential and the critical site of action of non-addicting glibenclamide in neuropathic pain$0

I01 · FY2021 · VA · contact PI

Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0

I01 · FY2021 · VA

Astrocyte regulation of the blood-brain barrier in intracerebral hemorrhage$386,250

R01 · FY2020 · HL · contact PI

Fn14, non-canonical NF-kappaB and downstream signaling in neuropathic pain$373,122

R01 · FY2020 · NS · contact PI

Non-canonical NF-kappaB signaling and Sur1-Trpm4 in traumatic brain injury$337,969

R01 · FY2020 · NS · contact PI

Therapeutic potential and the critical site of action of non-addicting glibenclamide in neuropathic pain$0

I01 · FY2020 · VA · contact PI

Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0

I01 · FY2020 · VA

Astrocyte regulation of the blood-brain barrier in intracerebral hemorrhage$386,250

R01 · FY2019 · HL · contact PI

Fn14, non-canonical NF-kappaB and downstream signaling in neuropathic pain$373,122

R01 · FY2019 · NS · contact PI

Non-canonical NF-kappaB signaling and Sur1-Trpm4 in traumatic brain injury$337,969

R01 · FY2019 · NS · contact PI

Gulf War neurotoxicants and acquired cognitive and neuropsychological dysfunction$0

I01 · FY2019 · VA · contact PI

Astrocyte regulation of the blood-brain barrier in intracerebral hemorrhage$386,250

R01 · FY2018 · HL · contact PI

Fn14, non-canonical NF-kappaB and downstream signaling in neuropathic pain$373,122

R01 · FY2018 · NS · contact PI

Non-canonical NF-kappaB signaling and Sur1-Trpm4 in traumatic brain injury$337,969

R01 · FY2018 · NS · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$335,781

R01 · FY2018 · NS · contact PI

Gulf War neurotoxicants and acquired cognitive and neuropsychological dysfunction$0

I01 · FY2018 · VA · contact PI

Non-canonical NF-kappaB signaling and Sur1-Trpm4 in traumatic brain injury$337,969

R01 · FY2017 · NS · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$335,781

R01 · FY2017 · NS · contact PI

Gulf War neurotoxicants and acquired cognitive and neuropsychological dysfunction$0

I01 · FY2017 · VA · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$335,781

R01 · FY2016 · NS · contact PI

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke$126,665

R01 · FY2016 · HL · contact PI

Gulf War neurotoxicants and acquired cognitive and neuropsychological dysfunction$0

I01 · FY2016 · VA · contact PI

Brain injury due to transcranial versus transthoracic blast exposure$0

I01 · FY2016 · VA · contact PI

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke$505,654

R01 · FY2015 · HL · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$335,781

R01 · FY2015 · NS · contact PI

MINIR-II: Minimally Invasive Neurosurgical Intracranial Robot$269,814

R01 · FY2015 · EB

MINIR-II: Minimally Invasive Neurosurgical Intracranial Robot$267,847

R01 · FY2015 · EB

Brain injury due to transcranial versus transthoracic blast exposure$0

I01 · FY2015 · VA · contact PI

MINIR-II: Minimally Invasive Neurosurgical Intracranial Robot$533,622

R01 · FY2014 · EB

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke$367,500

R01 · FY2014 · HL · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$335,781

R01 · FY2014 · NS · contact PI

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke$100,000

R01 · FY2014 · HL · contact PI

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke$90,445

R01 · FY2014 · HL · contact PI

Brain injury due to transcranial versus transthoracic blast exposure$0

I01 · FY2014 · VA · contact PI

MINIR-II: Minimally Invasive Neurosurgical Intracranial Robot$448,278

R01 · FY2013 · EB

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke$357,000

R01 · FY2013 · HL · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$310,308

R01 · FY2013 · NS · contact PI

Pathological role of the SUR1-regulated NC(Ca-ATP) channel in cortex after subara$310,308

R01 · FY2013 · NS · contact PI

Brain injury due to transcranial versus transthoracic blast exposure$0

I01 · FY2013 · VA · contact PI

MINIR-II: Minimally Invasive Neurosurgical Intracranial Robot$488,703

R01 · FY2012 · EB

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke$364,350

R01 · FY2012 · HL · contact PI

Pathological role of the SUR1-regulated NC(Ca-ATP) channel in cortex after subara$321,563

R01 · FY2012 · NS · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$321,563

R01 · FY2012 · NS · contact PI

Sulfonylurea receptor 1 (SUR1) - A novel therapeutic target in ischemic stroke$343,337

R01 · FY2011 · HL · contact PI

Pathological role of the SUR1-regulated NC(Ca-ATP) channel in cortex after subara$321,563

R01 · FY2011 · NS · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$321,563

R01 · FY2011 · NS · contact PI

Sulfonylurea receptor 1 (SUR1)- A novel therapeutic target in ischemic stroke$360,484

R01 · FY2010 · HL · contact PI

Pathological role of the SUR1-regulated NC(Ca-ATP) channel in cortex after subara$321,596

R01 · FY2010 · NS · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$318,208

R01 · FY2010 · NS · contact PI

Sulfonylurea receptor 1 (SUR1)- A novel therapeutic target in ischemic stroke$360,484

R01 · FY2009 · HL · contact PI

Pathological role of the SUR1-regulated NC(Ca-ATP) channel in cortex after subara$306,469

R01 · FY2009 · NS · contact PI

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channel$300,310

R01 · FY2009 · NS · contact PI

Sulfonylurea receptor 1 (SUR1)- A novel therapeutic target in ischemic stroke$355,727

R01 · FY2008 · HL · contact PI

Sulfonylurea receptor 1 (SUR1)- A novel therapeutic target in ischemic stroke$360,484

R01 · FY2007 · HL · contact PI

Cerebrovascular Ion Channels in Hypertension$281,609

R01 · FY2007 · HL · contact PI

Reactive astrocytes from gliotic capsule$260,490

R01 · FY2007 · NS · contact PI

Sulfonylurea receptor 1 (SUR1)- A novel therapeutic target in ischemic stroke$344,527

R01 · FY2006 · HL · contact PI

Cerebrovascular Ion Channels in Hypertension$290,021

R01 · FY2006 · HL · contact PI

Reactive astrocytes from gliotic capsule$268,270

R01 · FY2006 · NS · contact PI

Cerebrovascular Ion Channels in Hypertension$323,651

R01 · FY2005 · HL

Reactive astrocytes from gliotic capsule$274,725

R01 · FY2005 · NS

Cerebrovascular Ion Channels in Hypertension$322,000

R01 · FY2004 · HL

Reactive astrocytes from gliotic capsule$318,776

R01 · FY2004 · NS

PATHOPHYSIOLOGY OF NICOTINE IN CEREBRAL BLOOD VESSELS$259,875

R01 · FY2004 · NS

PATHOPHYSIOLOGY OF NICOTINE IN CEREBRAL BLOOD VESSELS$259,875

R01 · FY2003 · NS

PATHOPHYSIOLOGY OF NICOTINE IN CEREBRAL BLOOD VESSELS$259,875

R01 · FY2002 · NS

CEREBROVASCULAR ION CHANNELS IN HYPERTENSION$241,280

R01 · FY2002 · HL

PATHOPHYSIOLOGY OF NICOTINE IN CEREBRAL BLOOD VESSELS$259,875

R01 · FY2001 · NS

CEREBROVASCULAR ION CHANNELS IN HYPERTENSION$234,250

R01 · FY2001 · HL

PATHOPHYSIOLOGY OF NICOTINE IN CEREBRAL BLOOD VESSELS$286,330

R01 · FY2000 · NS

CEREBROVASCULAR ION CHANNELS IN HYPERTENSION$278,715

R01 · FY2000 · HL